Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Morpholinophenol → 2-[8-(Benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-(4-morpholin-4-yl-phenoxy)-propyl]-thiazole-4-carboxylic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Morpholinophenol | HCID 80510 | — |
| 반응물 | 2-[8-(Benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-{3-[4-(4-cyano-thiophen-3-yl)-phenoxy]-propyl]-thiazole-4-carboxylic acid | HCID 46836245 | — |
| 생성물 | 2-[8-(Benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-(4-morpholin-4-yl-phenoxy)-propyl]-thiazole-4-carboxylic acid | HCID 46836369 | — |
반응 단계
The title compound was prepared in a similar manner to the synthesis of compound 51 by substituting compound 51A with 4-morpholinophenol in step 2 of Example 51: 1H NMR (DMSO-d6): δ 7.96 (d, J=7.67 Hz, 1H), 7.72 (d, J=7.98 Hz, 1H), 7.60 (d, J=7.06 Hz, 1H), 7.27-7.42 (m, 4H), 6.88 (d, J=8.9 Hz, 2H), 6.75-6.79 (m, 2H), 4.76 (s, 2H), 3.85 (t, J=6.29 Hz, 2H), 3.64-3.68 (m, 6H), 3.07-3.11 (m, 2H), 2.95-2.98 (m, 6H), 1.87-1.94 (m, 2H). ESI (+)/MS: 656 (M+H)+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08232273B2 |
| 출처 데이터셋 | uspto-grants-2012_07 |
| ORD ID | ord-9125beac15ba49768def823e22e9a21d |
| 출처 메모 | uspto-grants-2012_07 |